Pretreatment ADC Histogram Analysis Is a Predictive Imaging Biomarker for Bevacizumab Treatment but Not Chemotherapy in Recurrent Glioblastoma

BACKGROUND AND PURPOSE: Pre-treatment ADC characteristics have been shown to predict response to bevacizumab in recurrent glioblastoma multiforme. However, no studies have examined whether ADC characteristics are specific to this particular treatment. The purpose of the current study was to determin...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:AJNR Am J Neuroradiol
Glavni autori: Ellingson, B.M., Sahebjam, S., Kim, H.J., Pope, W.B., Harris, R.J., Woodworth, D.C., Lai, A., Nghiemphu, P.L., Mason, W.P., Cloughesy, T.F.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Neuroradiology 2014
Teme:
Brain
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7965805/
https://ncbi.nlm.nih.gov/pubmed/24136647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A3748
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items